On page 5, the second sentence in the discussion section omitted a reference and contained a minor numerical error. The sentence should read:
Correction to: British Journal of Cancer (2016 Cancer ( ) 115, 188-194. doi: 10.1038 Cancer ( /bjc.2016 ; Published online 28 June 2016.
Upon publication of the above paper in the British Journal of Cancer, the authors identified several errors in their manuscript and Supplementary Material. Table 3 contained minor rounding errors and was incorrectly formatted. The correct table has been reproduced below.
On page 5, the second sentence in the discussion section omitted a reference and contained a minor numerical error. The sentence should read:
'Indeed, the median OS of patients in the nab-P þ Gem group who received a 2L treatment was over 4 months longer than the median OS with nab-P þ Gem in the ITT population (12.8 vs 8.7 months; Von Hoff et al, 2013; Goldstein et al, 2015) and over 6 months longer than the median OS with nab-P þ Gem in patients who did not receive 2L therapy (12.8 vs 6.3 months).' Supplementary Figure 1 has been replaced in the original supplementary file list, with a number of values having been changed.
The authors apologise for these oversights.
